Analystreport

Aptose Biosciences Inc. (NASDAQ: APTO) had its price target lowered by analysts at Royal Bank of Canada from $75.00 to $40.00.

Aptose Biosciences, Inc. - Common Shares  (APTO) 
Last aptose biosciences, inc. - common shares earnings: 3/10 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: aptose.com/investors